Does low vitamin D contribute to muscle weakness, pain, and poorer physical performance in older adults?

Vitamin D signaling is an essential regulator of skeletal muscle physiology, and its deficiency is closely linked to functional decline in older populations. Current research highlights that Vitamin D status influences everything from cellular protein synthesis to macroscopic physical performance.

Clinical evidence and physical performance

Observational data and clinical guidelines consistently associate low vitamin D levels—specifically serum 25(OH)D—with adverse muscle outcomes in geriatric populations.

• Strength and Performance: Deficiency is strongly correlated with sarcopenia, reduced handgrip and leg extension strength, and impaired physical performance metrics such as slower gait speed and poor balance.
• Fall Risk: Low status is a recognized risk factor for increased fall frequency and musculoskeletal pain, though the degree to which supplementation resolves existing pain varies across clinical trials.
• Supplementation Effects: While observational associations are strong, randomized controlled trials (RCTs) show mixed results. Meta-analyses of standard vitamin D3 (cholecalciferol) often show minimal effects on muscle mass in non-deficient individuals, whereas calcifediol has demonstrated more significant improvements in strength metrics.

Mechanistic explanations

The influence of Vitamin D on muscle is mediated through the Vitamin D Receptor (VDR), which is expressed directly in skeletal muscle myofibers and satellite cells.

• Genomic Action: Activated VDR acts as a transcriptional co-activator for approximately 3% of the human genome. It promotes myogenesis and protein synthesis by influencing factors like MyoD and the mTOR signaling pathway.
• Non-Genomic Action: VDR signaling rapidly modulates intracellular calcium fluxes and Src kinase pathways, which are critical for the excitation-contraction coupling required for muscle movement.
• Cellular Integrity: Disruption of VDR signaling triggers catabolic autophagy, leading to muscle fiber atrophy. Conversely, adequate signaling supports mitochondrial bioenergetics by increasing fatty acid oxidation and reducing the accumulation of intramyocellular lipids.

Bottom line

Low vitamin D status is a confirmed risk factor for muscle weakness and functional impairment in older adults. Maintaining adequate levels is necessary to support the complex genomic and non-genomic signaling pathways required for muscle fiber integrity and metabolic health.